Björn Wettermark

Uppsala University — Sweden

Economics, Econometrics and Finance · Social Sciences

54h-index11.0kcitations349works6.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(86), Pharmaceutical Practices and Patient Outcomes(69), Medication Adherence and Compliance(63), Pharmaceutical Economics and Policy(63), Pharmaceutical studies and practices(54)

Publications348 total

Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre‐ and Post–COVID‐19 in Sweden—An Interrupted Time Series Study
Basic & Clinical Pharmacology & Toxicology·2026Open Access
Dynamics of long-term adherence to lipid-lowering therapy in patients after myocardial infarction
European Journal of Clinical Pharmacology·2026
Improved persistence to statin therapy through a patient counseling intervention in community pharmacies – A nationwide cohort study
Exploratory Research in Clinical and Social Pharmacy·2025Open Access
Adherence trajectories of oral lipid-lowering therapy in patients with myocardial infarction and its estimated impact on low-density lipoprotein levels
Clinical Research in Cardiology·2025
Drug‐Induced <scp>QT</scp> Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes
Clinical Pharmacology & Therapeutics·2025· 1 citedOpen Access
Acute cardiovascular events following a severe COPD exacerbation – incidence, association with treatments, and impact of the COVID-19 viral pandemic
Epidemiology·2025
“We throw away an incredible amount of unused medicines“: Community pharmacy staff perspectives on environmental responsibility
Exploratory Research in Clinical and Social Pharmacy·2025· 1 citedOpen Access
Translation, Cultural Adaptation, and Validation of the Revised Patients' Attitudes Towards Deprescribing Questionnaire for Older Adults Into Greek
Cureus·2025Open Access
Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability
BioDrugs·2025Open Access
Impact of the COVID-19 pandemic on antidepressant use in eleven European regions: a comparative time series analysis 2018–2022
Social Psychiatry and Psychiatric Epidemiology·2025Open Access
The definition of treatment assignment in observational emulations of target trials – an empirical examination in the Swedish Primary Care Cardiovascular Database
Annals of Epidemiology·2025Open Access
Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries
PLoS ONE·2025Open Access
Towards greener prescribing? Swedish general practitioners' support for policies to reduce pharmaceutical pollution
British Journal of Clinical Pharmacology·2025Open Access
Do Swedish universities educate future doctors and pharmacists about the environmental impact of pharmaceuticals?
Currents in Pharmacy Teaching and Learning·2025· 1 citedOpen Access
Adherence to secondary preventive treatment following myocardial infarction with and without obstructive coronary artery disease
PLoS ONE·2025· 2 citedOpen Access
Towards greener prescribing? Swedish general practitioners' support for policies to reduce pharmaceutical pollution
British Journal of Clinical Pharmacology·2025· 3 citedOpen Access
Barriers to healthcare access and continuity of care among Ukrainian war refugees in Europe: findings from the RefuHealthAccess study
Frontiers in Public Health·2025· 9 citedOpen Access
Prescribing patterns of glucagon-like peptide-1 receptor agonists in the Swedish capital region—a register-based cross-sectional study
European Journal of Clinical Pharmacology·2025· 4 citedOpen Access
Medication adherence in the curricula of future European physicians, pharmacists and nurses – a cross-sectional survey
BMC Medical Education·2025· 4 citedOpen Access
Stakeholders’ Perspectives Toward the Use of Patient Registry Data for Decision-Making on Medicines: A Cross-Sectional Survey
Drug Safety·2025· 3 citedOpen Access
page 1 of 18Next →

Frequent Co-authors

Brian Godman(20), Lars L. Gustafsson(10), Morten Andersen(8), Paul Hjemdahl(7), Alan Haycox(7), Ulf Bergman(6), Marija Kalaba(6), Juan Jesús Carrero(5), Kristina Garuolienė(5), Ott Laius(5), Catherine Sermet(5), Tomas Forslund(5), Per Wändell(4), Thomas Kahan(4), Elisabetta Poluzzi(4), Vera Vlahović–Palčevski(4), Jan Hasselström(4), Alessandro Gasparini(4), Morgan E. Grams(4), Iain Bishop(4)